+Compare
CRL
Stock ticker:
NYSE
AS OF
Jul 1 closing price
Price
$218.66
Change
+$4.57 (+2.13%)
Capitalization
11.12B

CRL Price Prediction, Charles River Laboratories International AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jul 01, 2022

CRL in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 13, 2022

CRL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 33 cases where CRL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 24, 2022. You may want to consider a long position or call options on CRL as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CRL just turned positive on June 24, 2022. Looking at past instances where CRL's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRL advanced for three days, in of 372 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where CRL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.259) is normal, around the industry mean (6.885). P/E Ratio (26.667) is within average values for comparable stocks, (92.096). Projected Growth (PEG Ratio) (1.182) is also within normal values, averaging (4.201). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (3.105) is also within normal values, averaging (79.458).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

CRL is expected to report earnings to rise 1.09% to $2.78 per share on August 03

Charles River Laboratories International CRL Stock Earnings Reports
Q2'22
Est.
$2.78
Q1'22
Beat
by $0.03
Q4'21
Beat
by $0.06
Q3'21
Beat
by $0.12
Q2'21
Beat
by $0.23
The last earnings report on May 04 showed earnings per share of $2.75, beating the estimate of $2.72. With 275.65K shares outstanding, the current market capitalization sits at 11.12B.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 5.74B. The market cap for tickers in the group ranges from 775 to 3.72T. MKYSF holds the highest valuation in this group at 3.72T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -26%. HTGM experienced the highest price growth at 98%, while ABMT experienced the biggest fall at -77%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -68%. For the same stocks of the Industry, the average monthly volume growth was -34% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 71
SMR Rating: 67
Profit Risk Rating: 84
Seasonality Score: -3 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a provider of laboratory testing and research services on a contract basis

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
251 Ballardvale Street
Phone
+1 781 222-6000
Employees
20000
Web
https://www.criver.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEX27.930.56
+2.05%
Terex Corp
ACM65.590.37
+0.57%
Aecom
SXC6.78-0.03
-0.44%
Suncoke Energy
YTEN2.24-0.01
-0.44%
Yield10 Bioscience
DRIO5.93-0.21
-3.42%
DarioHealth Corp

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+2.27%
IQV - CRL
80%
Closely correlated
-0.89%
ICLR - CRL
72%
Closely correlated
-1.84%
DHR - CRL
71%
Closely correlated
+1.79%
A - CRL
70%
Closely correlated
+0.55%
BIO - CRL
69%
Closely correlated
+1.48%
More